Quotient Therapeutics的动态

Our academic co-founders contributed to this 2023 study published in Cell Press, highlighting how somatic mutations in liver cells can help to identify adaptive pathways in metabolic liver disease. The research is encouraging as we explore the possibilities of our #SomaticGenomics Platform and human target selection. Read the study here: https://bit.ly/4eCnQfT

  • 该图片无替代文字
Darren Nelson ?? (We're hiring)

Helping Life Sciences & Technology companies find top talent through personalized recruitment solutions.

4 个月

This is an exciting development! The exploration of adaptive pathways in metabolic liver disease through somatic mutations opens new avenues for treatment. Kudos to the academic co-founders and the team for their contributions to this significant study. Looking forward to seeing more groundbreaking work from the #SomaticGenomics Platform! ???? #Biotech #Genomics #LiverDisease

回复

要查看或添加评论,请登录